Ernst’s Medicaid Remark Sparks Outrage at Iowa Town Hall During a town hall in Butler County, Iowa, Senator Joni Ernst faced backlash after dismissing concerns over Medicaid cuts with the remark, “We all are going to die.” The comment, made in response to questions about the Trump-endorsed “One Big Beautiful Bill Act,” drew boos from constituents. Ernst later doubled down with a sarcastic…

*ahem*

(you don’t have to draw all of these, but)

Manfred Von RT, GodoRT again, just the RTcler, car RT (I just wanna make you draw a car, sorry), I think I saw maid RT in there, Dansune Miku, persona 5 joker RT again, my persona 5 RT design (biased), nagito RT, kokichi RT, chat parasite RT, magical john RT, vampire RT, aaaaand, sure, phoenix wright RT!

have fun mod >:) <3

here we go.

the list of dans (left-right, top-bottom):

FDA Approves First Cell-Based Therapy For Cancer

by Rob Stein / NPR Health

The Food and Drug Administration on Wednesday announced what the agency calls a "historic action", the first approval of a cell-based gene therapy in the United States.

The FDA approved Kymriah, which scientists refer to as a "living drug" because it involves using genetically modified immune cells from patients to attack their cancer.

Learn More About CAR-T Cell Therapy

The drug was approved to treat children and young adults suffering from acute lymphoblastic leukemia, a cancer of blood and bone marrow that is the most common childhood cancer in the United States. About 3,100 patients who are 20 and younger are diagnosed with ALL each year.

"We're entering a new frontier in medical innovation with the ability to reprogram a patient's own cells to attack a deadly cancer," FDA Commissioner Scott Gottlieb said in a written statement.

"New technologies such as gene and cell therapies hold out the potential to transform medicine and create an inflection point in our ability to treat and even cure many intractable illnesses," Gottlieb said.

The treatment involves removing immune system cells known as T cells from each patient and genetically modifying the cells in the laboratory to attack and kill leukemia cells. The genetically modified cells are then infused back into patients. It's also known as CAR-T cell therapy.

Read the entire article

🚀 GeneMedi is Participating in ASGCT 2026! We are excited to meet you at the ASGCT 2026 Annual Meeting – the world’s leading gene & cell therapy conference!

Event Details: 📍 Booth No. 1513 📅 May 11–15, 2026 📍 Boston Convention & Exhibition Center, MA

Discover our latest innovations at the booth: 🧪 AAV Purification & Titration Kits 🛡️ AAV Purification Resin and Column 🔬 Novel AAV Discovery Platform 🧬 Immune Cell Isolation Nano Beads & Kits 📊 CAR-Analytical Tools

Looking forward to connecting with researchers, scientists, and industry leaders working on advanced therapies.

Come visit us at Booth 1513!